BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20731190)

  • 1. Expression of cyclooxygenase-2 in neoplasms of the mammary gland in bitches.
    Badowska-Kozakiewicz AM; Malicka E
    Pol J Vet Sci; 2010; 13(2):337-42. PubMed ID: 20731190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of immunohistochemical expression of P-glycoprotein in neoplasms of the mammary gland in bitches.
    Badowska-Kozakiewicz AM; Malicka E
    Pol J Vet Sci; 2010; 13(2):343-7. PubMed ID: 20731191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-cadherin immunohistochemical expression in mammary gland neoplasms in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(1):47-54. PubMed ID: 18540208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical expression of protein p53 in neoplasms of the mammary gland in bitches.
    Rodo A; Malicka E
    Pol J Vet Sci; 2008; 11(2):89-95. PubMed ID: 18683536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical evaluation of expression of heat shock proteins HSP70 and HSP90 in mammary gland neoplasms in bitches.
    Badowska-Kozakiewicz AM; Malicka E
    Pol J Vet Sci; 2012; 15(2):209-14. PubMed ID: 22844695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase-2 expression in normal and neoplastic canine mammary cell lines.
    Brunelle M; Sartin EA; Wolfe LG; Sirois J; Doré M
    Vet Pathol; 2006 Sep; 43(5):656-66. PubMed ID: 16966442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of feline COX-2 and expression in feline mammary carcinomas.
    Sayasith K; Sirois J; Doré M
    Vet Pathol; 2009 May; 46(3):423-9. PubMed ID: 19176489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
    Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
    Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
    Queiroga FL; Pires I; Lobo L; Lopes CS
    Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAD51 protein expression is increased in canine mammary carcinomas.
    Klopfleisch R; Schütze M; Gruber AD
    Vet Pathol; 2010 Jan; 47(1):98-101. PubMed ID: 20080488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2, mPGES-1 and EP2 receptor immunohistochemical expression in canine and feline malignant mammary tumours.
    Millanta F; Asproni P; Canale A; Citi S; Poli A
    Vet Comp Oncol; 2016 Sep; 14(3):270-80. PubMed ID: 24824420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different role of COX-2 and angiogenesis in canine inflammatory and non-inflammatory mammary cancer.
    Clemente M; Sánchez-Archidona AR; Sardón D; Díez L; Martín-Ruiz A; Caceres S; Sassi F; Dolores Pérez-Alenza M; Illera JC; Dunner S; Peña L
    Vet J; 2013 Aug; 197(2):427-32. PubMed ID: 23489848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of iNOS, COX-2 and VEGF in canine mammary tumours and non-neoplastic mammary glands: Association with clinicopathological features and tumour grade.
    Anadol E; Yar Saglam AS; Gultiken N; Karakas K; Alcigir E; Alkan H; Kanca H
    Acta Vet Hung; 2017 Sep; 65(3):382-393. PubMed ID: 28956485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
    Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
    Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclooxygenase-2 expression in animal cancers.
    Doré M
    Vet Pathol; 2011 Jan; 48(1):254-65. PubMed ID: 20876365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COX-2 expression in canine and feline invasive mammary carcinomas: correlation with clinicopathological features and prognostic molecular markers.
    Millanta F; Citi S; Della Santa D; Porciani M; Poli A
    Breast Cancer Res Treat; 2006 Jul; 98(1):115-20. PubMed ID: 16538539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of p27 expression in canine mammary tumors and their metastases.
    Klopfleisch R; Schütze M; Gruber AD
    Res Vet Sci; 2010 Apr; 88(2):300-3. PubMed ID: 19748645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of CD44 adhesion factor in canine mammary carcinomas.
    Madrazo J; García-Fernández RA; García-Iglesias MJ; Durán AJ; Espinosa J; Pérez-Martínez C
    Vet J; 2009 Jun; 180(3):371-6. PubMed ID: 18299241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.